Top Markets
Coin of the day
ImmunoGen, Inc. ImmunoGen, Inc.

ImmunoGen, Inc.

IMGN
Classifica tra le azioni #3088
ImmunoGen, Inc. is a clinical-stage biotechnology enterprise that specializes... ImmunoGen, Inc. is a clinical-stage biotechnology enterprise that specializes in the creation of antibody-drug conjugate (ADC) therapies for cancer treatment. A prominent drug in their pipeline is mirvetuximab soravtansine, an ADC designed to target folate-receptor alpha (FRa), which is currently undergoing Phase III clinical trials for patients with platinum-resistant ovarian cancer. Another significant candidate, Pivekimab sunirine, a CD123-targeting ADC, is progressing through Phase II studies for acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Beyond its clinical efforts, the company's preclinical portfolio includes IMGC936, an ADC being co-developed with MacroGenics, Inc., and IMGN151, another anti-FRa therapeutic. ImmunoGen maintains strategic collaborations with a range of key industry players, such as Roche, Amgen/Oxford BioTherapeutics, Bayer HealthCare AG, Eli Lilly and Company, Novartis Institutes for BioMedical Research, Inc., CytomX Therapeutics, Inc., Fusion Pharmaceuticals Inc., Debiopharm International SA, and MacroGenics, Inc. Founded in 1980, ImmunoGen, Inc. is headquartered in Waltham, Massachusetts.
Prezzo delle azioni
$31.23
Ultima sincronizzazione: 2024-02-13
Capitalizzazione di mercato
$6.24B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia ImmunoGen, Inc. (IMGN)

Categoria

Storico del prezzo dell'azione per ImmunoGen, Inc. (IMGN)
Prezzo di chiusura più alto: $30.21 il 2024-02-01

Prezzo di chiusura più basso: $8.89 il 1989-11-01
Storico del prezzo dell'azione di ImmunoGen, Inc. dal 1989 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2024 2.21%
2023 489.22%
2022 -28.32%
2021 5.29%
2020 49.08%
2019 -9.93%
2018 -22.03%
2017 260.54%
2016 -86.73%
2015 56.16%
2014 -42.60%
2013 17.48%
2012 6.39%
2011 30.28%
2010 10.33%
2009 104.59%
2008 -8.33%
2007 -18.87%
2006 1.39%
2005 -29.82%
2004 48.39%
2003 53.96%
2002 -80.05%
2001 -26.61%
2000 400.25%
1999 95.33%
1998 131.85%
1997 -63.52%
1996 56.47%
1995 -41.57%
1994 -68.18%
1993 -19.49%
1992 -35.88%
1991 67.74%
1990 29.68%
1989 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$550.66 42.22%
US
$1.06K 49.14%
NL
$121.62 -12.98%
AU
$146.70 493.21%
US
$764.47 6.25%
CH